Gut Microbiota and Metabolome Dynamics Along Gastric Cancer Progression: An Exploratory Multi-Omics Analysis
Frontiers in Bioscience-Landmark · 2026
DOI: 10.31083/fbl46553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Jingfang Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, The People's Hospital of Chizhou, 247100 Chizhou, Anhui, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Metabolome, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2023 Chizhou City major science and technology special project.
Abstract (Originalsprache)
Background
Gastric cancer (GC) remains a major global health burden, particularly in East Asia, with complex etiologies involving Helicobacter pylori infection, diet, host genetics, and environmental exposures. GC development follows the Correa sequence (CS), a multistep cascade from gastritis to atrophy, erosion, and carcinoma. Although gut microbiota (GM) dysbiosis and metabolic reprogramming have each been implicated in GC, their integrated dynamics across CS remain incompletely defined.
Methods
We recruited participants across five groups: normal controls (G1), gastritis (G2), atrophy (G3), erosion (G4), and GC (G5). Fecal and gastric tissue samples were analyzed using 16S rRNA sequencing and untargeted metabolomics under both ion modes. Microbial diversity was assessed by α- and β-diversity indices, linear discriminant analysis effect size (LEfSe), and functional prediction. Metabolic features were profiled by UHPLC-Q Exactive Orbitrap MS, and differential metabolites were identified using t-tests and partial least squares discriminant analysis (PLS-DA). Diagnostic potential was evaluated using receiver operating characteristic (ROC) curves.
Results
Microbial α-diversity decreased significantly with progression, particularly in G3, while compositional shifts included depletion of Bacteroides and Faecalibacterium alongside enrichment of Actinobacteria, Peptostreptococcaceae, and Lachnoclostridium. LEfSe identified Bifidobacterium and Oscillospiraceae as potential biomarkers of advanced stages. ROC analyses demonstrated strong discriminatory power, with the class Actinobacteria achieving an area under the ROC curve (AUC) of 0.935 in distinguishing controls from GC. Fecal metabolomics revealed reductions in anti-inflammatory short-chain fatty acids (SCFAs) and increases in pro-inflammatory metabolites emerging at G3, while tissue metabolomics showed broader reprogramming in GC involving amino acid, nucleotide, lipid, and energy metabolism. Notably, erosion (G4) exhibited transitional features, whereas atrophy (G3) marked a distinct metabolic “breakpoint”.
Conclusions
By integrating GM and metabolomic data, this study delineates stage-specific microbial and metabolic alterations along the CS. Atrophy represents a pivotal inflection point in the transition from homeostasis to carcinogenesis, while erosion serves as a transitional state. Combined microbiota–metabolite signatures hold promise for non-invasive early detection, disease stratification, and mechanistic insights into metabolic dependencies in GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology Department, The People's Hospital of Chizhou, 247100 Chizhou, Anhui, China.
- Research and Development Center, Center of Human Microecology Engineering and Technology of Guangdong Province, 510700 Guangzhou, Guangdong, China.
Förderung
- 2023 Chizhou City major science and technology special project
Zitieren
APA
Yang, J., Wang, B., Yu, Y., Zhang, H., Zhou, X., Wu, G., Liu, Y., & Shi, X. (2026). Gut Microbiota and Metabolome Dynamics Along Gastric Cancer Progression: An Exploratory Multi-Omics Analysis. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl46553
Vancouver
Yang J, Wang B, Yu Y, Zhang H, Zhou X, Wu G, et al. Gut Microbiota and Metabolome Dynamics Along Gastric Cancer Progression: An Exploratory Multi-Omics Analysis. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl46553
BibTeX
@article{Yang2026,
author = {Yang, Jingfang and Wang, Binbin and Yu, Yanfei and Zhang, Hansheng and Zhou, Xueyong and Wu, Guangwen and Liu, Yan and Shi, Xiangyang},
title = {Gut Microbiota and Metabolome Dynamics Along Gastric Cancer Progression: An Exploratory Multi-Omics Analysis},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
doi = {10.31083/fbl46553}
}
EUVIMED